Newsquawk Daily European Equity Opening News - 30th October 2026

APAC stocks were mixed amid notable tech weakness, with the sector further pressured following disappointing earnings from Amazon and Intel, while participants also digested a slew of data at month-end. ASX 200 traded higher as softer yields helped offset the losses in tech, consumer staples and mining. Nikkei 225 was pressured amid the tech woes, while participants also digested a slew of mixed data releases and the BoJ policy announcement, in which the central bank kept rates unchanged, declared reaching the price target and accelerated the pace of its ETF sales. KOSPI underperformed and triggered a sidecar after the recent weak big tech earnings stateside. Hang Seng and Shanghai Comp were mixed amid a deluge of earnings and with Hong Kong outperforming as platform companies picked up the slack from chipmakers, while the mainland was subdued following a record number of purges at the Fifth Plenum.

CLOSES: Euro Stoxx 50 +0.72% at 6,212, Dax 40 +1.45% at 26,076, FTSE 100 +0.30% at 10,726, CAC 40 +1.05% at 7,970, FTSE MIB +0.39% at 50,018, IBEX 35 -0.16% at 18,853, PSI +0.80% at 9,320, SMI +1.29% at 14,769, AEX +0.59% at 1,142

Rio Tinto (RIO LN) - Co. suspends underground operations at its Oyu Tolgoi copper mine in Mongolia after a seismic event triggered a rockfall on Thursday, injuring three workers. Operations remain suspended pending a safety review. (Rio Tinto)

OTHER UK COMPANIES

BROKER MOVES

Haleon (HLN LN) upgraded to Hold from Sell at Deutsche Bank

Bayer (BAYN GY) - St. Louis jury unanimously rejects claims by three women alleging its Roundup weedkiller caused their cancers, marking the first verdict since a June US Supreme Court ruling effectively blocked lawsuits over inadequate cancer warnings. The latest case centred on allegations of defective product design, with Bayer facing tens of thousands of similar US lawsuits. (Bayer)

Volkswagen (VOW3 GY) - Audi's supervisory board is scheduled to hold an extraordinary meeting on Friday afternoon to discuss a planned US factory and the context of CEO Döllner's recent appearance with US President Trump, reports DPA citing sources. (DPA)

OTHER GERMAN COMPANIES

Fuchs (FPE3 GY) - 9M 2026 (EUR): Sales 3.13bln (prev. 2.70bln Y/Y), Net Income 281mln (prev. 228mln Y/Y), EBIT 409mln (prev. 326mln Y/Y). Raises FY26 guidance, sees revenue to c. 4.1bln (prev. guided significantly above 3.7bln) and EBIT to c. 500mln (prev. guided 460-480mln). (Fuchs)

Gerresheimer (GXI GY) - Q3 2026 (EUR): Revenue 605mln (exp. 577.8mln), Adj. EBITDA 103mln (exp. 106mln). Expects stronger Q4 performance with further earnings improvement, in line with guidance. Following the completed Centor disposal, preparations for the sale of its Primary Packaging Plastics (PPP) business are progressing well, with the transaction now expected to close in Q1 2027. (Gerresheimer)

BROKER MOVES

Aixtron (AIXA GY) upgraded to Buy from Hold at Danske Bank

Wacker Chemie (WCH GY) downgraded to Hold from Buy at Berenberg

AXA (CS FP) - 9M 2026 (EUR): Gross written premiums & other revenues 93bln, +5% Y/Y; Property & Casualty premiums 48.1bln, +3% Y/Y; Life & Health premiums 44.8bln, +1% Y/Y. Reaffirms FY26 outlook. (AXA)

Bouygues (EN FP) - Co. records an impairment on its stake in TF1 of EUR 569mln, corresponding to the full amount of goodwill relating to this stake. This charge will be recognised in non-current profit or loss and will reduce Bouygues' net profit attributable to the Group. It will have no impact on current operating profit from activities. (Bouygues)

Capgemini (CAP FP) - Q3 2026 (EUR): Revenue 6.07bln (prev. 5.39bln Y/Y), Bookings 5.40bln, +3.4% Y/Y. Raises FY26 constant currency revenue growth guidance to 9.0-9.5% (prev. guided 8.5-9.0%). (Capgemini)

Crédit Agricole (ACA FP) - Q3 2026 (EUR): Net Income 1.99bln (exp. 2.04bln), Revenue 7.09bln (exp. 7.00bln), Operating Costs 3.93bln (exp. 3.92bln), Cost of Risk 590mln (exp. 520mln), CET1 ratio 11.2% (exp. 11.4%), Asset Gathering Revenue 2.03bln (exp. 2.04bln), Large Customers revenue 2.30bln (exp. 2.21bln), French Retail Banking revenue 1.15bln (exp. 1.08bln), International Retail Banking revenue 1.00bln (exp. 1.04bln). CEO: “We are accelerating our expansion in Europe through the establishment of CA Deutschland and the planned acquisition of IKB, a key player in financing the German Mittelstand.” (Crédit Agricole)

Sanofi (SAN FP) - Q3 2026 (EUR): Business operating profit 5.43bln (exp. 4.32bln), Revenue 14.4bln (exp. 13.6bln), Adj. EPS 3.55 (exp. 2.81). Dupixent sales 5.69bln (exp. 5.2bln), recent pharmaceutical launches sales 1.39bln, +31% at constant FX; vaccine sales 3.19bln, -6.6% at constant FX. Raises FY26 sales growth guidance to low-teens at constant FX (prev. guided c. 10%) and business EPS growth to mid-teens at constant FX (prev. guided above 10%). CEO: “The whole organisation is focused on managing Sanofi's post-Dupixent trajectory over the next decade; our priority is to protect earnings through Dupixent's loss of exclusivity.” (Sanofi)

OTHER FRENCH COMPANIES

Eutelsat (ETL FP) - Q1 2027 (EUR): Revenue 286mln (exp. 303.4mln). Confirms FY 2026/27 objectives. IRIS²: Backlog includes EUR 8.9bln in programme revenues, expected to be recognised primarily between 2027 and 2031. Plans to invest EUR 2.23bln in shared infrastructure and EUR 1.16bln in commercial infrastructure between 2027 and 2034. Plans to deploy an additional 229 satellites beyond the 440 already procured, at a cost of c. EUR 1bln. Expects over EUR 10bln in commercial services revenue between 2032 and 2040 from its participation in the EU's IRIS² satellite network, a planned alternative to Starlink. (Eutelsat)

SCOR (SCR FP) - Q3 2026 (EUR): Net Income 206mln (prev. 217mln Y/Y), Insurance Revenue 3.76bln (prev. 3.71bln Y/Y), P&C insurance revenue 1.876bln (prev. 1.813bln Y/Y), P&C insurance service result 216mln (prev. 255mln Y/Y). (SCOR)

SPIE (SPIE FP) - Q3 2026 (EUR): Revenue 2.89bln (exp. 2.85bln). Confirms FY26 outlook. Says it saw exceptional performance in North-Western Europe and Germany, strong growth in Central Europe and improvement in France from the Q2 trough. (SPIE)

BROKER MOVES

CaixaBank (CABK SM) - Q3 2026 (EUR): Revenue from Services 1.41bln (prev. 1.30bln Y/Y), Pretax Profit 2.39bln (prev. 2.13bln Y/Y), Net Income 1.76bln (prev. 1.45bln Y/Y), NII 2.8bln (prev. 2.67bln Y/Y), Net Fee Income 1.05bln (prev. 0.98bln Y/Y). Raises its FY26 Revenue from Services guidance to above 5.6bln (prev. guided around 5% Y/Y). (CaixaBank)

Erste (EBS AV) - 9M 2026 (EUR): Operating Income 12bln (prev. 8.59bln Y/Y), NII 8.26bln (prev. 5.76bln Y/Y). Raises its FY26 RoTE guidance to above 20% and an increase in EPS of above 20%. (Erste)

Universal Music Group NV (UMG NA) - Q3 2026 (EUR): Adj. EBITDA 729mln (exp. 697.2mln), Revenue 3.39bln (exp. 3.38bln). Recorded Music subscription revenue rose 19.2% Y/Y at constant FX to 1.42bln (+9.5% excluding Downtown), supported by wholesale price increases and subscriber growth. Ad-supported streaming revenue increased 4.7% excluding Downtown, while physical revenue grew 17.4%, driven by broad-based demand across North America, Japan and Europe. Top-selling artists included Mrs. Green Apple, Olivia Rodrigo, Stray Kids, Ariana Grande and The Beatles. (UMG)

BROKER MOVES

OTHER SWISS COMPANIES

BROKER MOVES

Kongsberg Maritime (KMAR NO) - Q3 2026 (NOK): Revenue 6.64bln (exp. 6.76bln), EBITDA 1.04bln (exp. 1.1bln), Order Intake 8.32bln. (Kongsberg Maritime)

Loomis (LOOMIS SS) - Q3 2026 (SEK): Revenue 8.16bln (exp. 8.19bln), EBITA 1.23bln (exp. 1.16bln), Adj. EBIT 1.18bln (exp. 1.13bln). (Loomis)

Sparebanken Norge (SBNOR NO) - Q3 2026 (NOK): Net Operating Income 3.28bln (exp. 3.32bln), Pretax Profit 2.14bln (prev. 2.30bln Y/Y), Net Income 1.68bln (prev. 1.80bln Y/Y). (Sparebanken Norge)

Stora Enso (STERV FH) - Q3 2026 (EUR): Sales 2.24bln (exp. 2.36bln), Adj. EBITDA 320mln (exp. 307.2mln), Adj. EBIT 161mln (exp. 150.9mln). Guides FY26 capex around 500mln (prev. guided below 550mln). (Stora Enso)

YIT (YIT FH) - Q3 2026 (EUR): Adj. EBIT 30mln (exp. 28.8mln), Revenue 533mln (exp. 510.3mln). Narrows FY26 Group adj. operating profit guidance for continuing operations to EUR 80-90mln (prev. guided 70-100mln), reflecting stable financial performance across its businesses during 9M 2026. (YIT)

BROKER MOVES

SpareBank 1 Sor-Norge (SB1NO NO) downgraded to Hold from Buy at SEB

CLOSES: SPX -0.30% at 7,721, NDX -1.38% at 29,403, DJI -0.25% at 52,343, RUT +0.96% at 2,858

SECTORS: Communication Services -6.6%, Technology -0.88%, Consumer Discretionary -0.63%, Energy +0.42%, Materials +0.88%, Industrials +1%, Financials +1.52%, Utilities +1.56%, Consumer Staples +1.64%, Real Estate +2.25%, Health +2.5%.

Amazon (AMZN) - Amazon shares fell 7% in extended trade after higher than expected AI infrastructure spending, deteriorating free cash flow and slowing e-commerce and advertising growth overshadowed accelerating AWS revenue, which nevertheless fell short of heightened investor expectations. Q3 EPS 1.89 (exp. 1.97), Q3 revenue USD 201.9bln (exp. 202.2bln). Net income USD 20.7bln (exp. 21.5bln), operating income USD 28.08bln (exp. 26.06bln), operating margin 13.9% (exp. 12.9%). AWS revenue +39% Y/Y ex-FX to USD 45.98bln (exp. 45.68bln), AWS operating income USD 17.8bln, with AWS backlog reaching USD 578bln. North America sales USD 112.85bln (exp. 113bln), physical stores revenue USD 5.71bln (exp. 5.77bln). Online sales +2% Y/Y to USD 68.5bln; advertising revenue +11% Y/Y (vs 26% Y/Y in Q2), partly due to Prime Day moving from July to June. Q3 property and equipment spending, which traders see as a gauge for AI infrastructure spending, exceeded USD 77bln (vs USD 54.2bln in Q2), with trailing 12-month free cash flow seeing an outflow of USD 42.4bln. CEO Jassy highlighted accelerating AWS demand, with growth exceeding 39% and expectations for growth above 40% in both 2027 and 2028, supported by AI infrastructure investment. Sees Q4 revenue between USD 240-247bln (exp. 244.2bln), sees Q4 operating income between USD 28.5-33.5bln (exp. 33.2bln). Maintains FY26 cash capex outlook of approximately USD 220bln, with spending expected to rise meaningfully in 2027.

Gilead (GILD) - Gilead shares rose 2.3% in afterhours trading as stronger than expected quarterly earnings and revenue, driven by robust HIV portfolio sales, supported an upgraded FY product sales outlook, overshadowing a wider projected adjusted loss. Q3 adj. EPS 2.55 (exp. 2.19), Q3 revenue USD 8.30bln (exp. 7.80bln), Q3 net income USD 2.43bln (vs 3.05bln Y/Y). Product sales +13% Y/Y to USD 8.29bln, with sales excluding Veklury +16% Y/Y to USD 8.20bln. HIV revenue +18% Y/Y to USD 6.25bln, including Biktarvy sales +10% Y/Y to USD 4.1bln, while HIV prevention sales nearly doubled. Liver disease revenue +13% Y/Y to USD 927mln, oncology revenue +9% Y/Y to USD 860mln. CEO highlighted the strongest base business growth in over a decade, driven by HIV and oncology products. Raises FY26 product sales outlook; sees FY26 product sales between USD 31-31.3bln (exp. 30.54bln; prev. saw 30.1-30.4bln); lowers FY26 adj. EPS outlook, sees FY26 adj. EPS between -1.20 and -0.85 (exp. -0.40; prev. saw -0.65 to -0.30), reflecting approximately 9.88/shr in acquired R&D charges related to recent transactions.

Intel (INTC) - Intel shares plunged by almost 23% in extended trading after weaker than expected revenue, free cash flow and profit guidance, driven by prolonged PC market weakness, memory shortages and disruption at its Israeli factory, overshadowed stronger quarterly earnings and robust data centre demand. Q3 adj. EPS 0.52 (exp. 0.41), Q3 revenue USD 16.5bln (exp. 16.6bln). Adj. gross margin 44.1% (exp. 42.1%), adj. operating margin 19.6% (exp. 16.5%), adj. free cash flow USD 1.64bln (exp. 2.98bln). Client Computing revenue USD 8.10bln (exp. 8.82bln), Data Centre & AI revenue USD 7.32bln (exp. 6.67bln) and Intel Foundry revenue USD 6.70bln (exp. 6.12bln). CEO Lip-Bu Tan highlighted robust Xeon demand but acknowledged supply constraints, while management expects the PC market slowdown to persist through at least H1 2027 amid memory shortages. CFO Dave Zinsner said October's Kiryat Gat fab explosion and two-week shutdown would reduce Q4 revenue by approximately USD 300mln and gross margin by around 200bps, with a similar revenue impact expected in Q1 and further risks under assessment. Sees Q4 adj. EPS 0.25 (exp. 0.44), sees Q4 revenue between USD 15-16bln (exp. 17.1bln) and sees Q4 adj. gross margin 38%. Maintains FY26 capex outlook of approximately USD 20bln, with spending expected to increase significantly in 2027, and no positive free cash flow anticipated.

Nscale (NSCL), Nvidia (NVDA) - Nvidia is in talks to provide credit guarantees for an Nscale data centre facility that Anthropic (ANT) plans to use in West Virginia, equipped with Nvidia chips, according to The Information. The guarantees could amount to billions of dollars.

Reddit (RDDT) - Reddit shares plunged over 18% in afterhours following weaker than expected revenue and earnings guidance, alongside accelerating declines in search referral traffic and concerns over falling user activity. Q3 EPS 1.40 (exp. 1.33), Q3 revenue USD 895mln (exp. 878.4mln). Revenue over the trailing 12 months surpassed USD 3bln, with daily active unique users (DAUQs) at approximately 130mln. Management flagged a meaningful decline in search referral traffic during Q3, accelerating towards quarter-end and continuing into Q4. October search referrals declined by more than 1mln/week on average, primarily impacting logged-out and web traffic. Management warned that if current trends persist, total DAUQs could decline by a low double-digit percentage in Q4. Sees Q4 revenue between USD 1.0-1.03bln (exp. 1.05bln), and sees Q4 adj. EBITDA between USD 480-510mln (exp. 512.2mln).

Rivian (RIVN) - Rivian shares rallied by over 8% in extended trading after reporting a smaller than expected quarterly loss, driven by robust demand for its new R2 SUV, alongside an upgraded FY vehicle delivery outlook. Q3 adj. EPS -0.48 (exp. -0.65), Q3 revenue USD 2.155bln (exp. 2bln). Revenue was supported by strong initial demand for the R2 SUV, which became Rivian's best-selling vehicle by volume in its first full quarter on the market. Raised the lower end of FY26 vehicle delivery outlook; now sees FY26 vehicle deliveries between 67,000-70,000, and sees FY26 adj. EBITDA between USD -1.85 and -1.75bln. Separately, appointed Derek Mulvey as interim CFO, effective 30th October, following the departure of Claire McDonough.

Sandisk (SNDK) - Sandisk shares edged lower in extended US trading as weaker than expected operating cash flow and investor concerns over the sustainability of AI spending outweighed strong quarterly earnings, upbeat guidance and a stock split announcement. Q1 adj. EPS 49.51 (exp. 46.20), Q1 revenue USD 11.031bln (exp. 10.639bln). Q1 adj. net income USD 7.624bln (exp. 7.144bln), adj. operating income USD 8.871bln (exp. 8.44bln), operating cash flow USD 6.4bln (exp. 6.7bln). CEO highlighted robust and growing demand for flash storage products, particularly in the data centre business, supported by AI infrastructure investment and disciplined financial management; noted strong customer demand signals extending beyond FY30 and reiterated its focus on generating durable free cash flow. Sees Q2 adj. EPS between 55.00-57.00 (exp. 53.60), sees Q2 revenue between USD 12.2-12.6bln (exp. 12.3bln), sees Q2 gross margin between 84.5-85.5%. Announced an eight-for-one forward stock split; shares will be distributed after market close on 19th November, with split-adjusted trading beginning on 20th November.

Starbucks (SBUX) - Starbucks shares edged lower as weaker than expected revenue, disappointing international comparable sales and expectations of slowing North American sales growth outweighed stronger quarterly earnings and robust US sales performance. Q4 adj. EPS 0.80 (exp. 0.72), Q4 revenue USD 9.10bln (exp. 9.22bln). Adj. operating margin 14% (exp. 12.7%), global comparable sales +7.2% (exp. +6.23%), driven by average ticket growth of 5.2% and comparable transactions +1.8%. US comparable sales +7.7% (exp. +6.51%), international comparable sales +0.9% (exp. +3.36%). Management said it is ahead of schedule on its FY28 financial framework and expects further operating margin improvement in FY27. Sees FY27 adj. EPS between 3.15-3.25 (exp. 3.16), sees FY27 consolidated revenue declining approximately 1% Y/Y, primarily reflecting the transition of China retail operations to a licensed JV model. Sees FY27 North America comparable sales growth of approximately 4%, capex at approximately 5% of revenue, 90-100 net new North American stores and 2,000 North American store remodels, with approximately half of international store openings expected in China.

This is the standard daily European open digest, and the note's value lies in its composition rather than any single line. The dominant thread is a heavy cross-sector earnings slate in which guidance moves matter more than the prints themselves: several reporters beat on the quarter but were judged on the outlook, a pattern typical of late-cycle reporting seasons where positioning is already long and the bar sits in the forward commentary. Within that, the split worth drawing is between AI capex beneficiaries and AI capex funders: suppliers and insurers of the buildout have historically been treated differently from the platforms footing the bill, where the market's tolerance for rising spend against deteriorating free cash flow has thinned over successive quarters. The US tape's rotation out of growth into defensives and small caps is the classic post-megacap-print pattern, and the KOSPI sidecar fits the established read-across from weak US big tech into Korean semis. On the European single-name side, litigation and operational items follow their usual templates: jury verdicts in long-running product liability cases tend to reprice the tail risk rather than the cash flows, and mine suspensions after seismic events have historically mattered for copper supply only where restarts slip beyond initial safety reviews. The BoJ unchanged with an accelerated ETF disposal pace is incremental rather than regime change; the follow-ons are the European earnings still to come and whether the US defensive rotation persists into the cash session.